Page 6 - 2021_04-Haematologica-web

haematologica Journal of the Ferrata Storti Foundation
987 CD28.OX40 co-stimulatory combination is associated with long in vivo persistence and high activity of CAR.CD30 T cells Marika Guercio et al.
https://doi.org/10.3324/haematol.2019.231183
Acute Myeloid Leukemia
1000 The ASXL1G643W variant accelerates the development of CEBPA mutant acute myeloid leukemia Teresa D’Altri et al.
https://doi.org/10.3324/haematol.2019.235150
1008 Endogenous and combination retinoids are active in myelomonocytic leukemias Orsola di Martino et al.
https://doi.org/10.3324/haematol.2020.264432
1022 A novel combination regimen of BET and FLT3 inhibition for FLT3-ITD acute myeloid leukemia Lauren Y. Lee et al.
https://doi.org/10.3324/haematol.2020.247346
1034 Venetoclax combines synergistically with FLT3 inhibition to effectively target leukemic cells in FLT3-ITD+ acute myeloid leukemia models Raghuveer Singh Mali et al.
https://doi.org/10.3324/haematol.2019.244020
1047 Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a ten-color flow cytometric panel for initial workup and residual disease evaluation of blastic plasmacytoid dendritic cell neoplasm
Wei Wang et al.
https://doi.org/10.3324/haematol.2020.247569
Acute Lymphoblastic Leukemia
1056 Phase II-like murine trial identifies synergy between dexamethasone and dasatinib in T-cell acute lymphoblastic leukemia Yuzhe Shi et al.
https://doi.org/10.3324/haematol.2019.241026
1067 Combinatorial efficacy of entospletinib and chemotherapy in patient-derived xenograft models of infant acute lymphoblastic leukemia Joseph P. Loftus et al.
https://doi.org/10.3324/haematol.2019.241729
Plasma Cell Disorders
1079 Carfilzomib, cyclophosphamide and dexamethasone for newly diagnosed, high-risk myeloma patients not eligible for transplant: a pooled analysis of two studies
Roberto Mina et al.
https://doi.org/10.3324/haematol.2019.243428
Blood Transfusion
1086 Efficacy of UVC-treated, pathogen-reduced platelets versus untreated platelets: a randomized controlled non-inferiority trial Veronika Brixner et al.
https://doi.org/10.3324/haematol.2020.260430
Hematopoiesis
1097 Impact of luteinizing hormone suppression on hematopoietic recovery after intensive chemotherapy in patients with leukemia Iman Abou Dalle et al.
https://doi.org/10.3324/haematol.2020.256453
1106 Oncogenic Gata1 causes stage-specific megakaryocyte differentiation delay Gaëtan Juban et al.
https://doi.org/10.3324/haematol.2019.244541
Non-Hodgkin Lymphoma
1120 Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma Julia Garcia-Reyero et al.
https://doi.org/10.3324/haematol.2020.251579
Haematologica 2021; vol. 106 no. 4 - April 2021 http://www.haematologica.org/